The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Giuseppe Derosa

Department of Internal Medicine and Therapeutics

University of Pavia

Pavia

Italy

[email]@tin.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. 2003 - 2006
  • Department of Internal Medicine and Therapeutics, Section of Internal Medicine, Vascular and Metabolic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Italy. 2004

References

  1. Recommendations for the treatment of hypertension in patients with DM: critical evaluation based on clinical trials. Derosa, G., Salvadeo, S., Cicero, A.F. Curr. Clin. Pharmacol (2006) [Pubmed]
  2. Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension. Derosa, G., Cicero, A.F., D'Angelo, A., Tinelli, C., Ciccarelli, L., Piccinni, M.N., Pricolo, F., Salvadeo, S., Montagna, L., Gravina, A., Ferrari, I., Galli, S., Paniga, S., Fogari, R. J. Cardiovasc. Pharmacol. (2006) [Pubmed]
  3. Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. Derosa, G., Gaddi, A.V., Piccinni, M.N., Salvadeo, S., Ciccarelli, L., Fogari, E., Ghelfi, M., Ferrari, I., Cicero, A.F. Diabetes. Obes. Metab (2006) [Pubmed]
  4. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Derosa, G., D'Angelo, A., Ciccarelli, L., Piccinni, M.N., Pricolo, F., Salvadeo, S., Montagna, L., Gravina, A., Ferrari, I., Galli, S., Paniga, S., Tinelli, C., Cicero, A.F. Endothelium (2006) [Pubmed]
  5. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial. Derosa, G., Cicero, A.F., D'Angelo, A., Gaddi, A., Ciccarelli, L., Piccinni, M.N., Salvadeo, S.A., Pricolo, F., Ferrari, I., Gravina, A., Ragonesi, P.D. Clin. Ther (2006) [Pubmed]
  6. Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome. Derosa, G., Dangelo, A., Ragonesi, P.D., Ciccarelli, L., Piccinni, M.N., Pricolo, F., Salvadeo, S., Montagna, L., Gravina, A., Ferrari, I., Galli, S., Paniga, S., Cicero, A.F. J. Int. Med. Res. (2006) [Pubmed]
  7. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients. Derosa, G., Cicero, A.F., Murdolo, G., Piccinni, M.N., Fogari, E., Bertone, G., Ciccarelli, L., Fogari, R. Diabetes. Obes. Metab (2005) [Pubmed]
  8. Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. Derosa, G., Cicero, A.F., Gaddi, A., Mugellini, A., Ciccarelli, L., Fogari, R. J. Cardiovasc. Pharmacol. (2005) [Pubmed]
  9. Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. Derosa, G., Gaddi, A.V., Piccinni, M.N., Ciccarelli, L., Salvadeo, S., Peros, E., Ghelfi, M., Ferrari, I., Cicero, A.F. Pharmacotherapy (2005) [Pubmed]
  10. Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. Derosa, G., Gaddi, A.V., Ciccarelli, L., Fogari, E., Ghelfi, M., Ferrari, I., Cicero, A.F. J. Int. Med. Res. (2005) [Pubmed]
  11. A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. Derosa, G., Cicero, A.F., Gaddi, A., Ragonesi, P.D., Piccinni, M.N., Fogari, E., Salvadeo, S., Ciccarelli, L., Fogari, R. Diabetes Res. Clin. Pract. (2005) [Pubmed]
  12. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. Derosa, G., Avanzini, M.A., Geroldi, D., Fogari, R., Lorini, R., De Silvestri, A., Tinelli, C., Rondini, G., d'Annunzio, G. Diabetes Res. Clin. Pract. (2005) [Pubmed]
  13. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. Derosa, G., Cicero, A.F., Gaddi, A.V., Ciccarelli, L., Piccinni, M.N., Salvadeo, S., Pricolo, F., Fogari, E., Ghelfi, M., Ferrari, I., Fogari, R. Clin. Ther (2005) [Pubmed]
  14. Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. Derosa, G., Cicero, A.F., Dangelo, A., Gaddi, A., Ragonesi, P.D., Piccinni, M.N., Salvadeo, S., Ciccarelli, L., Pricolo, F., Ghelfi, M., Ferrari, I., Montagna, L., Fogari, R. Hypertens. Res. (2005) [Pubmed]
  15. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. Derosa, G., Cicero, A.F., Gaddi, A., Ragonesi, P.D., Fogari, E., Bertone, G., Ciccarelli, L., Piccinni, M.N. Clin. Ther (2004) [Pubmed]
  16. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study. Derosa, G., Ragonesi, P.D., Mugellini, A., Ciccarelli, L., Fogari, R. Hypertens. Res. (2004) [Pubmed]
  17. Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin. Derosa, G., Franzetti, I., Gadaleta, G., Ciccarelli, L., Fogari, R. Diabetes Nutr. Metab. (2004) [Pubmed]
  18. Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women. Derosa, G., Fogari, R., Piccinni, M.N., Peros, E., Bertone, G., Ciccarelli, L., Tinelli, C., Geroldi, D., Pannacciulli, N., De Pergola, G. Obes. Res. (2004) [Pubmed]
  19. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study. Derosa, G., Cicero, A.F., Bertone, G., Piccinni, M.N., Fogari, E., Ciccarelli, L., Fogari, R. Clin. Ther (2004) [Pubmed]
  20. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients. Derosa, G., Cicero, A.F., Murdolo, G., Ciccarelli, L., Fogari, R. Diabetes Nutr. Metab. (2004) [Pubmed]
  21. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa, G., Cicero, A.E., Bertone, G., Piccinni, M.N., Ciccarelli, L., Roggeri, D.E. Clin. Ther (2004) [Pubmed]
  22. Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors. Derosa, G., Mugellini, A., Ciccarelli, L., Crescenzi, G., Fogari, R. Clin. Ther (2003) [Pubmed]
  23. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet. Derosa, G., Mugellini, A., Ciccarelli, L., Fogari, R. Clin. Ther (2003) [Pubmed]
  24. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Derosa, G., Cicero, A.F., Gaddi, A., Mugellini, A., Ciccarelli, L., Fogari, R. Clin. Ther (2003) [Pubmed]
  25. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus. Derosa, G., Cicero, A.F., Ciccarelli, L., Fogari, R. Clin. Ther (2003) [Pubmed]
 
WikiGenes - Universities